WHF Emerging Leaders Program

Mark D. Huffman; Pablo Perel; Jean Luc Eisele; Darwin R. Labarthe; David A. Wood; Karen Sliwa; Salim Yusuf

doi:10.1093/eurheartj/ehx483

WHF Emerging Leaders Program

Mark D. Huffman, Pablo Perel, Jean Luc Eisele, Darwin R. Labarthe, David A. Wood, Karen Sliwa, Salim Yusuf

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2800-2803
Number of pages	4
Journal	European heart journal
Volume	38
Issue number	37
DOIs	https://doi.org/10.1093/eurheartj/ehx483
State	Published - Oct 1 2017

Access to Document

10.1093/eurheartj/ehx483

Cite this

@article{399198e88a4c4677b68c3b3928c1924e,

title = "WHF Emerging Leaders Program",

author = "Huffman, {Mark D.} and Pablo Perel and Eisele, {Jean Luc} and Labarthe, {Darwin R.} and Wood, {David A.} and Karen Sliwa and Salim Yusuf",

note = "Funding Information: The World Heart Federation{\textquoteleft}s Emerging Leaders program is supported by unrestricted educational grants from Boehringer Ingelheim, Novartis, AstraZeneca, and BUPA. Funding Information: Collaborative projects are supported by CHF 25 000 or more in seed funding provided by the World Heart Federation based on expert review of these proposals developed during think tank seminars, a key feature of this training program. The program is currently supported by unrestricted educational grants from Boehringer Ingelheim and Novartis with previous support from AstraZeneca and BUPA.",

year = "2017",

month = oct,

day = "1",

doi = "10.1093/eurheartj/ehx483",

language = "English",

volume = "38",

pages = "2800--2803",

journal = "European heart journal",

issn = "0195-668X",

number = "37",

}

TY - JOUR

T1 - WHF Emerging Leaders Program

AU - Huffman, Mark D.

AU - Perel, Pablo

AU - Eisele, Jean Luc

AU - Labarthe, Darwin R.

AU - Wood, David A.

AU - Sliwa, Karen

AU - Yusuf, Salim

N1 - Funding Information: The World Heart Federation‘s Emerging Leaders program is supported by unrestricted educational grants from Boehringer Ingelheim, Novartis, AstraZeneca, and BUPA. Funding Information: Collaborative projects are supported by CHF 25 000 or more in seed funding provided by the World Heart Federation based on expert review of these proposals developed during think tank seminars, a key feature of this training program. The program is currently supported by unrestricted educational grants from Boehringer Ingelheim and Novartis with previous support from AstraZeneca and BUPA.

PY - 2017/10/1

Y1 - 2017/10/1

UR - http://www.scopus.com/inward/record.url?scp=85030775847&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehx483

DO - 10.1093/eurheartj/ehx483

M3 - Article

C2 - 28982234

AN - SCOPUS:85030775847

SN - 0195-668X

VL - 38

SP - 2800

EP - 2803

JO - European heart journal

JF - European heart journal

IS - 37

ER -

WHF Emerging Leaders Program

Access to Document

Other files and links

Cite this